Active Ingredient: CARTEOLOL HYDROCHLORIDE
Proprietary Name: OCUPRESS
Dosage Form; Route of Administration: SOLUTION/DROPS; OPHTHALMIC
Strength: 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N019972
Product Number: 001
Approval Date: May 23, 1990
Applicant Holder Full Name: NOVARTIS PHARMACEUTICALS CORP
Marketing Status:
Discontinued
Patent and Exclusivity Information
